Death associated protein‑3 (DAP3) and DAP3 binding cell death enhancer‑1 (DELE1) in human colorectal cancer, and their impacts on clinical outcome and chemoresistance.
Sui L, Zeng J, Zhao H, Ye L, Martin TA, Sanders AJ, Ruge F, Jiang A, Dou QP, Hargest R, et al. Int J Oncol. 2023 Jan; 62(1). Epub 2022 Nov 16.